Related Experiment Video
Updated: May 26, 2026
09:11
Generation of Induced Pluripotent Stem Cells from Muscular Dystrophy Patients: Efficient Integration-free Reprogramming of Urine Derived Cells
Published on: January 28, 2015
[Induced pluripotent stem (iPS) cell-based cell therapy for muscular dystrophy: current progress and future
Takashi Nishiyama1, Shin'ichi Takeda
1Department of Molecular Therapy, National Institute of Neuroscience, Tokyo, Japan.
Brain and Nerve = Shinkei Kenkyu No Shinpo
|January 7, 2012
Summary
Induced pluripotent stem (iPS) cells offer a promising avenue for Duchenne muscular dystrophy (DMD) therapy. Research focuses on generating muscle stem cells from iPS cells for disease modeling and potential treatments.
Area of Science:
- Biomedical Science
- Stem Cell Biology
- Regenerative Medicine
Context:
- Duchenne muscular dystrophy (DMD) is a severe genetic muscle disorder lacking effective treatments.
- Muscle satellite cells are crucial for muscle repair but their transplantation has faced challenges.
- Patient-specific induced pluripotent stem (iPS) cells present a potential autologous cell source for DMD therapy.
Purpose:
- To explore strategies for generating muscle stem cells from iPS cells for DMD treatment.
- To discuss the potential of iPS cells as an in vitro disease model for DMD.
- To identify pathways for developing pharmaceutical treatments for muscle diseases.
Summary:
- Conditional overexpression of Pax3 or Pax7 in differentiating mouse embryoid bodies is a promising method for generating muscle stem cells from iPS cells.
- Current induction methods for human iPS cells are underdeveloped.
- iPS cells hold significant potential for creating in vitro models to study DMD pathology and test drug efficacy.
Impact:
- Advances in generating muscle stem cells from iPS cells could lead to novel therapeutic strategies for DMD.
- iPS cell-based disease models will accelerate the understanding of DMD pathogenesis.
- This research paves the way for developing targeted pharmaceutical interventions for DMD and other muscle disorders.
More Related Videos
07:44CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
Published on: September 14, 2019
10:03Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration
Published on: January 20, 2014
Related Concept Videos
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:21Satellite Stem Cells and Muscular Dystrophy
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...